Poolbeg Pharma (OTCQB: <a href= "https://www.otcmarkets.com/stock/POLBF/quote">POLBF</a>) is a clinical stage infectious disease pharmaceutical company with a capital light clinical model which is looking to develop multiple products faster and more cost effectively than the conventional biotech model. CEO Jeremy Skillington joins us to discuss how the Covid-19 pandemic has impacted the company's research on infectious diseases. <a href= "https://www.otcmarkets.com/files/OTCQBPodcast_Poolbeg%20Pharma_Season6Episode32.pdf" target="_blank" rel="noopener">View Podcast Transcript for Poolbeg Pharma</a>

Poolbeg Pharma (OTCQB: POLBF) is a clinical stage infectious disease pharmaceutical company with a capital light clinical model which is looking to develop multiple products faster and more cost effectively than the conventional biotech model. CEO Jeremy Skillington joins us to discuss how the Covid-19 pandemic has impacted the company's research on infectious diseases. View Podcast Transcript for Poolbeg Pharma

Poolbeg Pharma (OTCQB: <a href="https://www.otcmarkets.com/stock/POLBF/quote" rel="noopener noreferrer">POLBF</a>) is a clinical stage infectious disease pharmaceutical company with a capital light clinical model which is looking to develop multiple products faster and more cost effectively than the conventional biotech model. CEO Jeremy Skillington joins us to discuss how the Covid-19 pandemic has impacted the company's research on infectious diseases. <a href="https://www.otcmarkets.com/files/OTCQBPodcast_Poolbeg%20Pharma_Season6Episode32.pdf" rel="noopener noreferrer">View Podcast Transcript for Poolbeg Pharma</a>

Poolbeg Pharma

OTC Markets presents our podcast series on the OTCQB Market, where we interview the entrepreneurs behind the companies that trade on the venture market.

Share Poolbeg Pharma

Sign up to save your podcasts

Poolbeg Pharma

Poolbeg Pharma